Trial Profile
A prospective observational study evaluating effect of sorafenib on hepatitis C virus viremia in cirrhotic patients with hepatocellular carcinoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2016
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C; Liver cancer
- Focus Therapeutic Use
- 28 Dec 2016 New trial record
- 30 Oct 2016 Results presented at the IDWeek 2016